Umary Acido Hialuronico recalled over undeclared diclofenac
- Recall date
- July 18, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- MAIN PRODUCTS INC recalls Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
- Recall number
- D-0626-2024
- FDA classification
- Class I
- Brand / firm
- MAIN PRODUCTS INC
- Sold / distributed
- Nationwide within the U.S
Why it was recalled
Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
Get recall alerts
Free email alert whenever MAIN PRODUCTS INC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: MAIN PRODUCTS INC